ClinicalTrials.gov｜肠外营养在研试验· CorMedix Therapeutics·· 20 天前AI 评分34
CorMedix启动DefenCath预防TPN导管相关血流感染III期试验
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
AI 导读
CorMedix Therapeutics登记一项III期随机双盲对照试验（NCT06822426），评估DefenCath（牛磺罗定联合肝素封管液）对比肝素在经中心静脉导管接受全肠外营养的成人与青少年中降低中心线相关血流感染（CLABSI）的安全性与有效性。
来源：ClinicalTrials.gov｜肠外营养在研试验 · clinicaltrials.gov